CRYOPORT, INC. Available-for-sale Securities, Gross Realized Gains
CRYOPORT, INC. (CYRX) reported Available-for-sale Securities, Gross Realized Gains of $29.90 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-09.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGains · last filed 2019-08-09
- CRYOPORT, INC. available-for-sale securities, gross realized gains for the quarter ending 2019-06-30 was $24.00K.
- CRYOPORT, INC. available-for-sale securities, gross realized gains for the quarter ending 2019-03-31 was $5.90K.
| Period end | Available-for-sale Securities, Gross Realized Gains 3 month | Available-for-sale Securities, Gross Realized Gains 6 month |
|---|---|---|
| 2019-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $29.90K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $5.90K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |